EUVIMEDEUVIMED entdecken
Crossref

Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K Akt MTOR pathway

Nan Li, Zhenghua Zhang, Guodan Jiang, Honglan Sun, Deming Yu

Frontiers in Bioscience · 2019 · 24 (2) · 303-312

DOI: 10.2741/4719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience, 2019. Verfasst von Nan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsApoptosisCell Line, TumorCell ProliferationCell SurvivalColorectal NeoplasmsDrug SynergismFlavonesHT29 CellsHumansOxaliplatinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine Kinases

Substanzen

Antineoplastic AgentsFlavonesOxaliplatinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinasesnobiletin

Autor:innen und Institutionen

  • Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China.
  • Department of Oncology, Jing'an District Central Hospital of Shanghai, Fudan University, Shanghai, 200040, China, doxzzh@qq.com.
  • Department of General Surgery,Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China.

Zitieren

APA

Li, N., Zhang, Z., Jiang, G., Sun, H., & Yu, D. (2019). Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K Akt MTOR pathway. Frontiers in Bioscience, 24(2), 303-312. https://doi.org/10.2741/4719

Vancouver

Li N, Zhang Z, Jiang G, Sun H, Yu D. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K Akt MTOR pathway. Frontiers in Bioscience. 2019;24(2):303-312. doi:10.2741/4719

BibTeX
@article{Li2019,
  author = {Li, Nan and Zhang, Zhenghua and Jiang, Guodan and Sun, Honglan and Yu, Deming},
  title = {Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K Akt MTOR pathway},
  journal = {Frontiers in Bioscience},
  year = {2019},
  volume = {24},
  number = {2},
  pages = {303--312},
  doi = {10.2741/4719}
}
Kostenlos starten →